CAP2 study sheds light on genetic cause of heart disease
15 December 2015 | By Victoria White
Researchers have shown that the presence or absence of the CAP2 gene causes sudden cardiac death in mice...
List view / Grid view
News
Kyoto University and Takeda T-CiRA Programme begins
15 December 2015 | By Victoria White
The "Takeda-CiRA Joint Programme for iPS Cell Applications" (T-CiRA) will begin research in six core directions to explore clinical applications of stem cells in therapeutic areas including cancer, heart failure and diabetes mellitus...
Construction starts at Imperial’s new Babraham facility
15 December 2015 | By Victoria White
The new facility will support science- and technology-based companies striving to build businesses that originated with research from universities and increase their impact...
Scientists identify gene variant linked to bipolar disorder
15 December 2015 | By Victoria White
A new study, conducted by researchers at the Karolinska Institutet and Gothenburg University, describes a possible mechanism for how the gene variant produces clinical symptoms by affecting levels of specific proteins in the brain...
Harnessing antibiotic resistance to fight amyloid diseases
14 December 2015 | By Victoria White
A new study outlines a way of using antibiotic resistance to find chemicals capable of stopping amyloid formation in amyloid diseases such as Parkinson’s, Alzheimer’s and type II diabetes...
Abbott and UCSF discover human pegivirus 2 linked to HCV
14 December 2015 | By Victoria White
Their research identified eight complete strains of human pegivirus 2, which makes it the first study to reveal the entire genetic makeup of this new virus...
BMS and UCLA team up for immuno-oncology collaboration
14 December 2015 | By Victoria White
Bristol-Myers Squibb and the David Geffen School of Medicine at UCLA will conduct a range of early phase clinical studies as part of the I-O RPM research programme...
Bellicum to develop PSCA cancer therapies using Agensys technology
14 December 2015 | By Victoria White
Bellicum has been granted rights to develop and commercialise adoptive cell therapies for tumours expressing Prostate Stem Cell Antigen (PSCA) using PCSA technology in-licensed and developed at Agensys...
Scientists show how drug molecules regulate β2AR
11 December 2015 | By Victoria White
A new study shows how different pharmaceutical drugs hit either the "on" or "off" switch of β2AR - signalling protein linked to asthma, obesity and type 2 diabetes...
ImmBio initiates First-in-Human study of PnuBioVax
11 December 2015 | By Victoria White
The study will look at the safety and tolerability of PnuBioVax for three different dosages against the bacterial pathogen Streptococcus pneumoniae...
AstraZeneca and MedImmune to harness the power of the Secretome
11 December 2015 | By Victoria White
The companies have joined WCPR to develop new technologies for biologics production and to identify new targets for disease research in the ground-breaking area of the Secretome...
SRI and Stanford Cancer Institute in ‘first-in-class’ collaboration
10 December 2015 | By Victoria White
SRI Biosciences and physician-researchers from Stanford Cancer Institute (SCI) are to pursue development of novel compounds to treat multiple forms of cancer and other conditions...
Big data unlocks new targets to treat influenza
10 December 2015 | By Victoria White
A team of scientists have tapped into publically available large-scale 'Omics' databases to identify new targets to treat influenza...
Takeda and Cour in coeliac disease collaboration
10 December 2015 | By Victoria White
The partnership will focus on using nanotechnologies based on Cour’s Tolerizing Immune Modifying nanoParticle (TIMP) platform...
Gene therapy early-stage pipeline looks strong, says GBI Research
9 December 2015 | By Victoria White
The gene therapy pipeline has more than 900 products in development, and the early-stage pipeline looks particularly strong with 76% of products at either the discovery or preclinical stage...